PL2663318T3 - Kompozycja farmaceutyczna do leczenia raka - Google Patents
Kompozycja farmaceutyczna do leczenia rakaInfo
- Publication number
- PL2663318T3 PL2663318T3 PL12702318T PL12702318T PL2663318T3 PL 2663318 T3 PL2663318 T3 PL 2663318T3 PL 12702318 T PL12702318 T PL 12702318T PL 12702318 T PL12702318 T PL 12702318T PL 2663318 T3 PL2663318 T3 PL 2663318T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical composition
- treating cancer
- cancer
- treating
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN92MU2011 | 2011-01-11 | ||
PCT/IB2012/050120 WO2012095789A1 (en) | 2011-01-11 | 2012-01-10 | Pharmaceutical composition for treating cancer |
EP12702318.2A EP2663318B1 (en) | 2011-01-11 | 2012-01-10 | Pharmaceutical composition for treating cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2663318T3 true PL2663318T3 (pl) | 2015-08-31 |
Family
ID=54264167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL12702318T PL2663318T3 (pl) | 2011-01-11 | 2012-01-10 | Kompozycja farmaceutyczna do leczenia raka |
Country Status (10)
Country | Link |
---|---|
US (2) | US20130295648A1 (pl) |
EP (1) | EP2663318B1 (pl) |
JP (1) | JP5889335B2 (pl) |
CN (1) | CN103338779B (pl) |
AU (1) | AU2012206322B2 (pl) |
CA (1) | CA2824417C (pl) |
ES (1) | ES2536842T3 (pl) |
PL (1) | PL2663318T3 (pl) |
RU (1) | RU2580888C2 (pl) |
WO (1) | WO2012095789A1 (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2824417C (en) * | 2011-01-11 | 2019-02-26 | Cadila Pharmaceuticals Limited | Mycobacterium w for use in treating cancer |
JP6421208B2 (ja) * | 2017-02-28 | 2018-11-07 | カディラ ファーマシューティカルズ リミテッド | がん抗原 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003049751A1 (en) * | 2001-12-10 | 2003-06-19 | Bakulesh Mafatlal Khamar | The process of manufacturing a pharmaceutical composition useful for management of cancer |
UA79952C2 (en) * | 2001-12-10 | 2007-08-10 | Kabulesh Mafatlal Khamar | MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT |
WO2003089462A2 (en) * | 2002-04-16 | 2003-10-30 | Jun Liu | Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
US20100086911A1 (en) * | 2005-03-03 | 2010-04-08 | Ryosuke Katsuyama | Preventive/therapeutic agent for cancer |
US20100104536A1 (en) * | 2007-03-20 | 2010-04-29 | Indravadan Ambalal Modi | P38 inhibitors |
CA2824417C (en) * | 2011-01-11 | 2019-02-26 | Cadila Pharmaceuticals Limited | Mycobacterium w for use in treating cancer |
EP2729166B1 (en) * | 2011-07-05 | 2017-09-06 | Cadila Pharmaceuticals Limited | Cancer antigen |
-
2012
- 2012-01-10 CA CA2824417A patent/CA2824417C/en active Active
- 2012-01-10 PL PL12702318T patent/PL2663318T3/pl unknown
- 2012-01-10 US US13/978,923 patent/US20130295648A1/en not_active Abandoned
- 2012-01-10 WO PCT/IB2012/050120 patent/WO2012095789A1/en active Application Filing
- 2012-01-10 EP EP12702318.2A patent/EP2663318B1/en active Active
- 2012-01-10 CN CN201280007529.5A patent/CN103338779B/zh active Active
- 2012-01-10 ES ES12702318.2T patent/ES2536842T3/es active Active
- 2012-01-10 JP JP2013548916A patent/JP5889335B2/ja active Active
- 2012-01-10 AU AU2012206322A patent/AU2012206322B2/en active Active
- 2012-01-10 RU RU2013136780/15A patent/RU2580888C2/ru active
-
2015
- 2015-02-23 US US14/628,534 patent/US9415078B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN103338779A (zh) | 2013-10-02 |
EP2663318A1 (en) | 2013-11-20 |
CA2824417C (en) | 2019-02-26 |
US20130295648A1 (en) | 2013-11-07 |
JP2014502631A (ja) | 2014-02-03 |
ES2536842T3 (es) | 2015-05-29 |
RU2580888C2 (ru) | 2016-04-10 |
CA2824417A1 (en) | 2012-07-19 |
US9415078B2 (en) | 2016-08-16 |
EP2663318B1 (en) | 2015-03-18 |
WO2012095789A1 (en) | 2012-07-19 |
AU2012206322B2 (en) | 2016-09-01 |
JP5889335B2 (ja) | 2016-03-22 |
US20150290255A1 (en) | 2015-10-15 |
AU2012206322A1 (en) | 2013-08-29 |
RU2013136780A (ru) | 2015-02-20 |
CN103338779B (zh) | 2015-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1232158A1 (zh) | 用於治療肝癌的藥物 | |
IL234989B (en) | Compounds and preparations containing them for the treatment of cancer | |
HUE044611T2 (hu) | Gyógyászati készítmény rák kezelésére | |
PL2824114T3 (pl) | Kompozycja farmaceutyczna do leczenia nowotworu | |
IL227429A0 (en) | The components and methods of cancer treatment | |
AP3864A (en) | Pharmaceutical composition | |
GB201118232D0 (en) | Pharmaceutical composition | |
EP2635286A4 (en) | METHOD FOR THE TREATMENT OF CANCER | |
IL228644A0 (en) | Cancer treatment methods | |
HK1185874A1 (zh) | 用於治療癌症的新的 -氨基- -羥基-苯甲酰胺 | |
HK1189158A1 (en) | Pharmaceutical composition | |
EP2774917A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES | |
IL229231A0 (en) | Preparations and methods for the treatment of cancer | |
SG11201400976WA (en) | Methods and pharmaceutical compositions for treating cancer | |
ZA201503005B (en) | Ingenol-derived compounds useful for treating cancer | |
HRP20180875T1 (hr) | Kombinacijska terapija raka jajnika | |
EP2727593A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL | |
EP2711010A4 (en) | PHARMACEUTICAL COMPOSITION | |
HUP1100444A2 (en) | Pharmaceutical composition | |
PL2663318T3 (pl) | Kompozycja farmaceutyczna do leczenia raka | |
EP2785343A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYPERLIPIDEMIA | |
EP2712621A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERPROLIFERATIVE DISEASES | |
EP2709623A4 (en) | MEDICINES AND METHODS FOR TREATING CANCER | |
HUP1100445A2 (en) | Pharmaceutical composition | |
HK1213809A1 (zh) | 用於治療肥胖症的藥物組合物 |